Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation

Jeroen M. Hendriks; Celine Gallagher; Prashanthan Sanders

doi:10.1136/heartjnl-2017-311305

Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation

Jeroen M. Hendriks, Celine Gallagher, Prashanthan Sanders

Research output: Contribution to journal › Editorial

8 Citations (Scopus)

Abstract

Atrial fibrillation (AF) is a significant burden for healthcare systems due to increased morbidity and mortality rates. It is a major cause of ischaemic stroke, which is considered one of the most serious and disabling complications of AF. Stroke prevention with oral anticoagulation (OAC) by vitamin K antagonists (VKA) or non-vitamin K antagonists (NOAC) is therefore a significant component of AF management. Both VKAs and NOACs are effective for the prevention of stroke in AF; however, stringent adherence to the recommended treatment regimen is crucial, both from a prescriber’s and a patient’s perspective.

Original language	English
Pages (from-to)	1308-1309
Number of pages	2
Journal	Heart
Volume	103
Issue number	17
DOIs	https://doi.org/10.1136/heartjnl-2017-311305
Publication status	Published - Sep 2017
Externally published	Yes

Keywords

Atrial fibrillation
Health care delivery
Medication adherence
Stroke

Access to Document

10.1136/heartjnl-2017-311305Licence: In Copyright

Fingerprint Dive into the research topics of 'Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation'. Together they form a unique fingerprint.

Cite this

@article{aad66ffae472483db114dd09fed1a332,

title = "Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation",

abstract = "Atrial fibrillation (AF) is a significant burden for healthcare systems due to increased morbidity and mortality rates. It is a major cause of ischaemic stroke, which is considered one of the most serious and disabling complications of AF. Stroke prevention with oral anticoagulation (OAC) by vitamin K antagonists (VKA) or non-vitamin K antagonists (NOAC) is therefore a significant component of AF management. Both VKAs and NOACs are effective for the prevention of stroke in AF; however, stringent adherence to the recommended treatment regimen is crucial, both from a prescriber{\textquoteright}s and a patient{\textquoteright}s perspective.",

keywords = "Atrial fibrillation, Health care delivery, Medication adherence, Stroke",

author = "Hendriks, {Jeroen M.} and Celine Gallagher and Prashanthan Sanders",

year = "2017",

month = sep,

doi = "10.1136/heartjnl-2017-311305",

language = "English",

volume = "103",

pages = "1308--1309",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishsing Group",

number = "17",

}

TY - JOUR

T1 - Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation

AU - Hendriks, Jeroen M.

AU - Gallagher, Celine

AU - Sanders, Prashanthan

PY - 2017/9

Y1 - 2017/9

N2 - Atrial fibrillation (AF) is a significant burden for healthcare systems due to increased morbidity and mortality rates. It is a major cause of ischaemic stroke, which is considered one of the most serious and disabling complications of AF. Stroke prevention with oral anticoagulation (OAC) by vitamin K antagonists (VKA) or non-vitamin K antagonists (NOAC) is therefore a significant component of AF management. Both VKAs and NOACs are effective for the prevention of stroke in AF; however, stringent adherence to the recommended treatment regimen is crucial, both from a prescriber’s and a patient’s perspective.

AB - Atrial fibrillation (AF) is a significant burden for healthcare systems due to increased morbidity and mortality rates. It is a major cause of ischaemic stroke, which is considered one of the most serious and disabling complications of AF. Stroke prevention with oral anticoagulation (OAC) by vitamin K antagonists (VKA) or non-vitamin K antagonists (NOAC) is therefore a significant component of AF management. Both VKAs and NOACs are effective for the prevention of stroke in AF; however, stringent adherence to the recommended treatment regimen is crucial, both from a prescriber’s and a patient’s perspective.

KW - Atrial fibrillation

KW - Health care delivery

KW - Medication adherence

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85027567863&partnerID=8YFLogxK

U2 - 10.1136/heartjnl-2017-311305

DO - 10.1136/heartjnl-2017-311305

M3 - Editorial

C2 - 28389521

AN - SCOPUS:85027567863

VL - 103

SP - 1308

EP - 1309

JO - Heart

JF - Heart

SN - 1355-6037

IS - 17

ER -

Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation

Abstract

Keywords

Access to Document

Other files and links

Cite this